Nasus Pharma Ltd. Ordinary Shares (NY:NSRX)
Press Releases about Nasus Pharma Ltd. Ordinary Shares
Could Nasal Powders Be the Next Revolution in Emergency Medicine?
November 03, 2025
Via AB Newswire
Topics
Initial Public Offering
Nasus Pharma Receives $22 Price Target and Buy Rating From Laidlaw & Company
September 29, 2025
Via AB Newswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>